Purchase Order 75N93021P01454

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...

The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for a peptide synthesis facility to conduct storage and stability studies of drug substances and products. As the prime contractor, Polypeptide Labs will perform the requested studies at its location in San Diego, California over a one year period from August 1, 2016...

This federal contract award, with the ID HHSN272201000653P, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Mimotopes Inc., a for-profit manufacturer of goods, on June 11, 2010. The $11,344.00 firm fixed-price purchase order is for the delivery of a "TAS::75 0885::TAS RECOVERY ACT PEPSET PEPTIDE LIBRARY>5 UMOL, W SOLUBILITY INFO" and has a completion date of July 9, 2010. The contract is not set aside for any specific business type. This award...

This federal contract award to Protein Technologies Inc. (PTI), a subsidiary of Mesa Laboratories Inc., is for the provision of a Tribute Peptide Synthesizer System to the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services. The $128,828.40 firm-fixed-price purchase order is designated as a total small business set-aside. PTI, the global leader in peptide synthesis equipment and services, has supported research, testing, and analytical...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm-fixed-price purchase order to Cyclope Bio SL for $80,000 on August 1, 2026. Performance occurs in Spain with an ultimate completion date of July 31, 2027. The order procures 200 grams of (1S,2S)-trans-N-Boc-1,2-cyclopentanediamine, a chemical precursor for synthesizing cyclopentane peptide nucleic acids and thyclotides in support of preclinical HIV detection, prevention, and treatment research funded by the NIH...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bio-Synthesis, Inc., a Hispanic American-owned small business. The contract is for custom peptide synthesis services, with a ceiling value of $3,259.00 and an ultimate completion date of February 25, 2015. The contract was awarded on February 18, 2015 and did not use a set-aside....

<p>The Defense Logistics Agency issued a $2,340.36 delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection). Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 5, 2026.</p>

<p>The Defense Logistics Agency issued a $12,690.54 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection) under the company's IDC with DLA Troop Support Medical.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of March 2, 2026. No set-aside was used.</p>

This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to the vendor Proteinsimple (also known as Bio-Techne Corporation Division). The $12,075 contract is for the supply of a CUSTOM SIMPLE PLEX CARTRIDGE KIT FOR 32 SAMPLES, HUMAN in order to continue testing of leptin, growth hormone, BDNF, and insulin in goat protocol samples. There was no set-aside used for this award, which has a completion...

<p>The Defense Logistics Agency issued a $65,231.57 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Zepbound 15 mg/0.5 mL pen (tirzepatide injection), with ultimate completion scheduled for February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed price structure with no set-aside applied.</p>